Patent · US Active

Combination treatment with strontium for the prophylaxis and/or treatment of cartilage and/or bone conditions

US8623422B2 · kind B2 · utility

2Cited by

71References

20Claims

0Family size

Assignee

Osteologix A/S · DK

Inventors

Christian Hansen · Hannover, DE
Henrik Nilsson · Copenhagen, DK
Stephan Christgau · Copenhagen, DK

Key dates

Filing date	May 4, 2009
Grant date	Jan 7, 2014
Priority date	—
Expiry date	Nov 13, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A combination treatment, wherein a strontium-containing compound together with one or more active substances capable of reducing the incidence of bone fracture and/or increasing bone density and/or improving healing of fractured bone and/or improving bone quality are administered for use in the treatment and/or prophylaxis of cartilage and/or bone conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.